Ouro Medicines is a biotechnology company developing immune reset therapeutics for chronic immune-mediated diseases, with a focus on B cell biology and T cell engagers.

Saluda Medical develops and commercializes the Evoke® System, a closed-loop spinal cord stimulation device for managing chronic pain.

Adcendo is a biotech company focused on developing antibody-drug conjugates for treating cancers with high unmet needs.

Vinted is an online marketplace that allows users to buy, sell, and exchange second-hand fashion and electronics.

Eruditus partners with global universities to offer executive education programs, primarily generating revenue from international markets.

Sudo Biosciences is a biopharmaceutical company developing TYK2 inhibitor candidates for the treatment of multiple sclerosis, neurodegenerative, and immune-mediated dermatologic diseases.

Bicara Therapeutics is a clinical-stage biotech company focused on developing BCA101, a novel bifunctional inhibitor targeting EGFR and TGF-β pathways for the treatment of various cancers.

RefleXion Medical develops and commercializes SCINTIX therapy, a novel treatment for all stages of indicated solid tumor cancers, including metastatic disease, delivered via the RefleXion X1 platform.

MBrace Therapeutics is a biopharmaceutical company developing a lead antibody-drug conjugate (ADC) candidate, MBRC-101, targeting the EphA5 receptor tyrosine kinase present in various cancers, with the recent completion of an $85 million Series B financing round.

UBQ Materials is a climate tech company that specializes in creating a sustainable plastic substitute called UBQ from residual waste, which is used by major brands to reduce landfill waste and emissions.

Denodo is a global leader in data management, specializing in data virtualization software that enables enterprises to create unified views of disparate data sources, thereby democratizing the use of data in any IT corporate system.